In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
The commercial real estate industry is finally confronting years of delayed financial reality as banks begin calling in billions in troubled loans, pushing office loan delinquencies to record highs. With more than 12 percent of office loans now delinquent and nearly a trillion dollars in commercial and multifamily debt maturing this year, lenders are tightening standards and forcing borrowers to present real data, stronger strategies, and actionable plans. Regional banks face the most risk, while real estate professionals who master data literacy and investment analysis will be best positioned to thrive in this new era.
CFP professionals are in higher demand than ever, and new data from SmartAsset and the CFP Board shows that some states are becoming hotspots for this booming field. California leads the nation, now home to nearly one in every ten Certified Financial Planners. As Americans seek deeper financial guidance, states with strong economies and growing populations are seeing the fastest rise in licensed advisors—signaling major opportunity for both new and seasoned professionals.
After years of market disruption, commercial real estate is finally showing strong signs of a comeback, with major investment firms projecting 2026 as the year the sector fully stabilizes. New reports from Hines, CBRE, and Colliers point to rising leasing activity, renewed buyer appetite, and a rebound toward pre‑pandemic investment levels. Manhattan is leading the recovery, premium office spaces are dominating demand, and suburban markets are gaining traction—setting the stage for significant opportunities for real estate professionals, investors, and brokers preparing for the next market cycle.
The 2026 labor market is entering a “low‑hire, low‑fire” freeze—job openings remain above pre‑pandemic levels, yet companies are delaying hiring decisions as they navigate economic uncertainty, tariffs, and shifting immigration policies. Despite the slowdown, major pockets of growth remain, especially in healthcare, construction, civil engineering, and Sunbelt regions. AI is reshaping some industries but replacing very few jobs, with less than 1% of skills at high risk of automation. For professionals willing to adapt, upskill, or shift industries, 2026 offers strategic opportunities—particularly in licensed fields like real estate, mortgage, insurance, and finance, where education and credentials can unlock stability and upward mobility.
Mortgage rates slipped to 6.09% this week, marking their lowest point in three years and surprising analysts after strong job numbers. The drop improves affordability for many families and signals a pivotal moment for buyers, investors, and real estate professionals as market conditions cool and stabilization continues into 2026.
Artificial intelligence is now the driving force behind the fastest‑growing proptech companies, with AI-native startups claiming the majority of the $16.7 billion invested in real estate technology last year. From tenant communication automation to self‑navigating construction vehicles and AI-powered investor management systems, four new unicorns—EliseAI, Bedrock Robotics, Juniper Square, and Vantaca—are leading a sweeping shift across commercial real estate. Their rise signals a new era where professionals must embrace automation, data skills, and continuous education to stay competitive in an industry evolving at record speed.
